PURACERE is a patent protected and clinically researched dietary supplement that is the purist yeast beta-1,3/1,6-D-glucan available. It is manufactured in the United States by Immudyne via a proprietary process and is sold to some of the world’s largest cosmetic companies and is used in Immudyne’s cosmetic products marketed directly to consumers around the world.

Proven through hundreds of studies and centuries of clinical experience, beta-glucans are powerful in supporting immune health. Clinical research has demonstrated that yeast beta-1/3, 1/6-D-glucan activates neutrophils, B-lymphocytes, T-helper cells, NK1 cells, and macrophages to destroy harmful pathogens such as bacteria, fungi, protozoan, and pre-malignant and malignant cancer cells. These naturally derived compounds also have potent anti-oxidant properties that assist in the body’s natural detoxification process. Other studies have shown that yeast beta-1,3/1,6-D-glucan increases immune system cell count, stimulates new tissue growth, and accelerates wound healing.

Specifically, Immudyne’s beta-1,3/1,6-D-glucan has been extensively researched by many renowned medical laboratories, including; Baylor College of Medicine, US Armed Forces Radiobiology Institute, Stanford University, Southwest Research Institute, Case Western Reserve University, the University of Arkansas, North Caroline State University, The University of Bern in Switzerland, and the China Agricultural University, China.

Scientific Advisory Board

Joseph V. DiTrolio, MD

  •  – Clinical Professor of Surgery, Urology at New Jersey Medical School
  • – Diplomate of The American Board of Urology, AOA Honor Society
  • – Executive Founding Editor of The Journal of Medicine of New Jersey

Steven D. Shapiro, M.D

  • – Co-Founder of Shapiro MD
  • – Board-Certified Dermatologist
  • – Specializes in laser procedures & reconstructive skin cancer surgery
  • – Chairman of the Board for Healthcare Underwriters’ Group (HUG)

Michael T. Borenstein, M.D., Ph.D.

  • – Co-Founder of Shapiro MD
  • – Board-Certified Dermatologist
  • – Specializes in Medical, Surgical, and Cosmetic Dermatology
  • – Graduate of Columbia University and University of Miami

Lilliana Ramirez, MD

  • – Spokesperson for InateMD
  • – Board-Certified Dermatologist
  • – American Academy of Dermatology Fellow
  • – Published in the American Journal of Dermatopathology

Dr. Sven Rohmann, PhD

  • – 10 years at Merck Serono Oncology / Erbitux
  • – Venture Capital Fund Manager for Novartis Pharma AG
  • – Managing Partner and General Partner at Nextech Venture AG

Dr Stephen Petteruti, D.O., AOA, ABBM, AAAM

  • – Diplomat, National Board of Osteopathic Examiners
  • – Board certified in Bariatric Medicine
  • – Member of American Academy of Anti-Aging Medicine